학술논문

Erythema dyschromicum perstans (ashy dermatosis) during the treatment with infliximab in a child with Crohn disease
Document Type
article
Source
Przegląd Dermatologiczny, Vol 101, Iss 1, Pp 27-34 (2014)
Subject
erythema dyschromicum perstans
ashy dermatosis
Crohn disease
infliximab
Medicine
Dermatology
RL1-803
Language
English
Polish
ISSN
0033-2526
2084-9893
Abstract
Introduction . Erythema dyschromicum perstans (EDP) or ashy dermatosis is a rare, benign acquired disease characterized by macular hyperpigmentations. The cause of EDP is unclear although some drugs, toxic agents and internal disorders have been associated with this dermatosis. Objective . Presentation of the first case of the association between EDP and Crohn disease treated with infliximab. Case report . We present a case of a 15-year-old boy with Crohn disease who was treated with infliximab. During the treatment asymptomatic, hyperpigmented macules on the trunk were observed. Based on clinical and histopathological features the diagnosis of erythema dyschromicum perstans was established. Conclusions . Erythema dyschromicum perstans may be associated with Crohn disease and infliximab.